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Abstract 
Background: The main human dietary source for n-3 highly unsaturated fatty 
acids (HUFAs) is fish and seafood. In farmed fish, n-3 HUFA content has been 
reduced because of increased pressure to replace fish oil by vegetable oils in 
aqua-feeds. Recently a strategy combining genetic selection with changes in diet 
formulations has been proposed to improve n-3 HUFA content in farmed 
Atlantic salmon. n-3 HUFA composition has been shown to be a heritable trait 
in Atlantic salmon. Further, genes involved in the HUFA biosynthetic pathway 
in Atlantic salmon can be regulated by fatty acids in the diet. Therefore, the aim 
of this study was to investigate if variation exists, in the expression of genes 
regulating the n-3 HUFA biosynthesis pathway, between different Atlantic 
salmon families. Further, we wanted to study the influence of different levels of 
oleic acid (OA, 18:1 n-9) and docosahexaenoic acid (DHA, 22:6 n-3) on n-3 
fatty acid metabolism in hepatocytes. 
Result: Liver samples from 1044 salmon from 103 families (ca 10 fish per 
family), were analysed for ∆6fad gene expression. Of this, twelve families 
were analysed for EPA and DHA composition. The results showed that the 
gene expression levels of ∆6fad_b were differently expressed between the 
families. According to this difference, 6 families of Atlantic salmon were 
selected as “high expression families” and 6 families were selected as “low 
expression families”. The levels of the n-3 HUFAs DHA and eicosapentaenoic 
acid (EPA, 20:5 n-3) although not significant, were slightly higher in “high 
expression families” than in the “low expression families”. Atlantic salmon 
hepatocytes were isolated and pre-incubated with increasing ratios of 
DHA/OA (100 OA, 75OA/25DHA, 25OA/75DHA) in order to change the 
intracellular level of these fatty acids. Then the hepatocytes were incubated 
with radio-labelled [1-
14
C] 18:3 n-3. After incubation the main radio-labelled 
products were the desaturation product 18:4 n-3 and the desaturation and 
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elongation products EPA, DHA and 22:5 n-3. Increasing OA content in 
incubation media led to a significant increase in the production of 
radio-labelled EPA. Radio-labelled DHA showed a tendency to be higher in 
the 100OA and 75OA/25DHA groups than in the100DHA and 25OA/75DHA 
groups. 
 
Conclusions: The in vivo results showed that Atlantic salmon families have 
different expression levels of the Δ6fad gene which possibly influences the 
capacity to produce n-3 HUFA. The in vitro study results showed that 
pre-incubation of salmon hepatocytes with increasing ratios of OA may 
increase the EPA and DHA synthesis. 
 
Key words: Elongases, desaturases, Atlantic salmon, n-3 fatty acids, DHA, EPA, 
gene expression, 
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1. Introduction  
Marine fish oils have traditionally been used as the only dietary lipid source for 
farmed salmon, since it contain high level of n-3 highly unsaturated fatty acids 
(HUFA) (Reviewed by Turchini et al. 2009). Fish oil can satisfy dietary 
requirements for the energy and essential fatty acids for optimal growth and 
health of farmed fish (Reviewed by Tocher 2003). Aquaculture industry is still 
highly dependent upon fish oil and fish meal. However, fish oil supply from 
capture fisheries cannot satisfy the increasing fish meal and fish oil demand 
from the aquaculture industry (Tacon et al. 2006; Gatlin et al. 2007). According 
to FAO (2012), global fish oil production decreased from 1.50 million tonnes in 
1994 to 1.07 million tonnes in 2009. And analysis of the data for the last 15 
years (1994-2009) indicates that global fish oil production from marine capture 
fisheries have been decreasing at annual average rates of 2.6 %. But aquaculture 
industry is currently the fastest growing food production sector in the world. 
Aquaculture production is projected to reach about 79 million tonnes in 2021, 
rising by 33 % over the period 2012-2021. It requires that the supply of feed 
inputs will also have to grow at similar ratios so as to meet demand. The rapidly 
growing aquaculture industry cannot continue to rely on finite stocks of marine 
fish as a supply of fish oil. In addition, this strong market demand for fish meal 
and fish oil lead to increasing market cost for these finite commodities.  
 
Therefore, it is necessary to find cheap and sustainable alternatives to fish oil. 
Vegetable oils are considered as the only sustainable alternatives to fish oil 
today. The production of vegetable oils has increased considerably and the 
prices of the three major vegetable oils (soybean, rapeseed and sunflower oils) 
have historically been lower than the price of fish oil (Reviewed by Turchini et 
al. 2009). 
 
Current research show that vegetable oils are readily digested and further 
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catabolised by fish as an energy source for growth (Bell et al. 2001; Regost et al. 
2003; Stubhaug et al. 2007). However, vegetable oils do not contain n-3 HUFAs 
as marine fish oils. Vegetable oils are rich sources of n-6 and n-9 fatty acids, 
mainly linoleic acid (LA, 18:2 n-6) and oleic acid (OA, 18:1 n-9). Thus, dietary 
requirements for n-3 polyunsaturated fatty acids (PUFA) of the fish, limit 
vegetable oils as the single alternative to fish oil. The diets containing blends of 
vegetable oils and fish oil have been shown to give good fish growth in salmon 
farming (Ruyter et al. 2000a; Los & Murata 1998; Torstensen et al. 2005). 
However, the blending of vegetable oils and fish oil in the diets, leads to less of 
the very long chain n-3 fatty acids, and consequently lower nutritional value of 
the salmon fillets (Sargent et al. 2002; Bell et al. 2003 a; b). 
 
In Norway, farmed Atlantic salmon have been selected for increased growth rate 
since 1975 (Gjedrem et al. 1991), together with improvements in nutrition and 
management. Recently, a study showed that deposition and/or retention of the 
dietary n-3 HUFA docosahexaenoic acid (DHA, 22:6 n-3) and eicosapentaenoic 
acid (EPA, 20:5 n-3) in the flesh, is a highly heritable trait (h
2 
= 0.77 ± 0.14) in 
salmon (Leaver et al. 2011). This suggests that families with high flesh n-3 
HUFA content might have a good ability to retain/maintain/synthesize n-3 
HUFA (Schlechtriem et al. 2007). Families with high level of flesh n-3 HUFA 
can be selected to maintain levels of flesh n-3 HUFA when fed diets formulated 
with vegetable oils and reduced proportions of fish oil (Schlechtriem et al. 
2007). The use of selective breeding programs to enhance traits of commercial 
importance is becoming increasingly more common in aquaculture (Gjedrem & 
Baranski 2009). 
 
Combining genetic selection with changes in commercial feed formulations 
(i.e., higher levels of inclusion of vegetable) may be a viable strategy to meet 
worldwide demand for farmed fish without compromising animal welfare or 
nutritional value (Morais et al. 2011). Information on the molecular genetics 
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and mechanisms of the n-3 HUFA biosynthetic pathway in salmon enables the 
possibility of optimizing the use of vegetable oils in the feed for Atlantic 
salmon. Previous studies from our group have shown that the capacity for 
biosynthesis of n-3 HUFA, and the gene expression of the Δ5 fatty acid 
desaturase (Δ5fad) and Δ6 fatty acid desaturase (Δ6fad) activities in salmon is 
reduced when fed high dietary levels of fish oil, while vegetable oils increase 
the capacities (Ruyter et al. 2003; Moya Falcon et al. 2005; Kjær et al. 2008). 
However, there is still a lot we do not know about optimal ratios of different 
oils which gives optimal production of DHA and EPA. Therefore, the main 
objective of this thesis was to find variations in Δ6fad gene expression and 
EPA and DHA level. Further, the second aim was to study how different 
cellular levels of DHA and OA influence the n-3 fatty acids metabolism in 
hepatocytes. 
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2. Literature review  
2.1 Lipids and fatty acids 
Lipids are hydrophobic compounds that are soluble in organic solvents. They 
mainly include triacylglycerols, phospholipids, wax esters and sterols. Fatty 
acids are an important constituent of most lipids. Triacylglycerols constitute a 
major class of neutral lipid and consist of three molecules of fatty acids 
esterified to the three alcohol groups of glycerol (Tocher et al. 2003). 
Phospholipids are a major class of polar lipids and phosphoglycerides are the 
most common of the phospholipids. Phosphoglycerides also consist of a 
glycerol with two fatty acid chains and characterized by a 
phosphate-containing polar hydroxyl group. In salmon, the main site of lipid 
storage is the flesh (myosepta) and visceral adipose tissue, while the liver 
plays a major role in processing of triacylglycerols and phosphoglycerides, 
including modification of fatty acid chain lengths and the degree of 
unsaturation (Sargent et al. 1993). 
 
Fatty acids are usually divided into saturated, monounsaturated and 
polyunsaturated fatty acids according to their degree of unsaturation (number of 
ethylenic or “double” bonds). Saturated fatty acids lack double bonds, 
monounsaturated fatty acids possess only one double bond, whereas PUFA 
contain two or more double bonds. PUFA, having carbon chain lengths ≥ C20 
and with ≥ 3 ethylenic bonds, are defined as HUFA (Henderson & Tocher 1987; 
Sargent et al. 2002; Tocher 2003). PUFA can be defined by the first double 
bond position relative to the methyl terminus of the fatty acids chain. n-3 means 
that the first double bond occurs between the third and fourth carbons from the 
methyl end of the fatty acids chain, whereas in the n-6 series the double bond is 
between the sixth and seventh carbons (Menon & Dhopeshwarkar 1982). 
 
Literature review  
 
5 
 
Triacylglycerols plays a major role for the storage in fish (Tocher et al. 2003). 
The phospholipids are structural components of biomembranes and have 
particularly important roles in fish and human nutrition (Reviewed by Sargent et 
al. 1999). In fish, DHA and EPA are the major HUFAs of cell membranes. 
DHA and EPA are both involved in maintaining cell membrane structure and 
function (Reviewed by Sargent et al. 1999). Especially, the retina and brain of 
fish are characteristically rich in DHA (Tocher & Harvie 1988). In human, DHA 
and EPA have many health beneficiary effects, in particular prevention of 
cardiovascular disease and they are fundamental to brain function (Kidd 2007).  
2.2 Dietary lipids 
In fish, dietary lipids are an important source of energy for regular growth, 
health, reproduction and body functions. High proportion of the dietary lipid is 
used for energy production, thus potentially sparing dietary protein for muscle 
growth. Improvements in growth, feed utilization efficiency and nutrient 
retention in fish fed energy-dense diets (Sargent et al. 2002). The lipid content 
of feed is important as a source of dietary energy, but is also fundamental in 
supplying essential fatty acids (Sargent et al. 2002). A fatty acid is commonly 
termed ‘essential fatty acid’ when its biosynthesis de novo is not possible; thus, 
it must be supplied within the diet (Reviewed by Turchini et al. 2009). 
Long-term absence of essential fatty acids from the diet leads to deficiency 
symptoms like reduced growth and increased mortality in fish (Reviewed by 
Glencross 2009). In general, 18:3 n-3 and/or 18:2 n-6 could satisfy the essential 
fatty acid requirements of freshwater fish, whereas the n-3 HUFA, DHA and 
EPA, are required to meet the essential fatty acid requirements of marine fish 
(Yone 1978; Watanabe 1982; Kanazawa 1985). Salmon is an anadromous 
species, which hatched in fresh water and then spends most of their life in the 
sea and returns to fresh water to spawn. Therefore, salmon require 18:3 n-3 and 
18:2 n-6 as well as certain amounts of DHA and EPA as essential fatty acids 
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(Ruyter et al. 2000a; Ruyter & Thomassen 1999). 
 
Dietary lipids in fish are largely composed of a combination of triacylglycerols 
and phospholipids, with sterols, free fatty acids, pigments and waxes (Reviewed 
by Glencross 2009). These dietary lipids break down into smaller components 
by lipases in order to be easily absorbed into the intestine. The digestion of 
lipids in fish is found along the entire digestive tract, including the stomach, 
pyloric caeca and proximal and distal intestines of most fish (Reviewed by 
Glencross 2009). There is limited information on the specifics of lipase 
functionality in fish. The main triacylglycerol lipase in salmon is a bile 
salt-activated lipase (Olsen & Ringo 1997). Dietary phosphoglycerides are 
presumably digested by pancreatic or intestinal phospholipases (Henderson & 
Tocher 1987; Sargent et al. 1989). The main products of lipid digestion in fish 
are free fatty acids from all classes of lipids. In addition, glycerol can be 
products from digestion of triacyglycerols. The majority of phosphoglycerides 
are digested to 1-acyl lysophosphoglyceride (Tocher 2010).  
 
These digestion products are further solubilized or emulsified in bile salt 
micelles, followed by absorption into the cells of the digestive tissue (Smith et 
al. 1983). Long chain fatty acids appear to be mainly absorbed in the mid 
intestine, while middle chain fatty acids are absorbed in the pyloric caeca 
(Denstadli et al. 2004). Once assimilated into the cells, free fatty acids are 
activated with a Coenzyme A (CoA) molecule to get the resultant product, fatty 
acyl CoA (Reviewed by Glencross 2009). Then the fatty acyl CoA combines 
with assimilated acyl glycerols and lysophospholipids to re-synthesize 
triacylglycerols and phosphoglycerides (Sargent et al. 1989). This re-synthesize 
process is called re-esterification (Reviewed by Glencross 2009). This is the 
primary lipid biosynthetic process of dietary-derived lipids (Smith et al. 1983). 
The lipid that is not re-esterified could be catabolised by the process of 
β-oxidation or subjected to modification process such as elongation/desaturation 
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(Reviewed by Glencross 2009). 
2.3 Fatty acid oxidation 
The oxidation of fatty acids which starts at the β-carbon with removal of two 
carbon units is termed β-oxidation. Fatty acids are most commonly degraded 
in series of β-oxidation reaction (Schulz 2002; Tocher 2003).The β-oxidation 
of fatty acids occurs in two different organelles, the mitochondria and the 
peroxisomes (Tocher 2003). Heart, liver, and red muscle are the most 
important tissues involved in β-oxidation in fish (Henderson & Tocher 1987; 
Henderson 1996; Bilinski et al. 1970). Mitochondrial β-oxidation dominates 
in these tissues except in livers where the peroxisomal β-oxidation may 
represent significant amount of total β-oxidation (Crockett & Sidell 1993a; b). 
Peroxisomal β-oxidation shortens HUFAs, which are poor substrates for 
mitochondrial β-oxidation. After being oxidized in peroxisomes, the shortened 
fatty acids enter mitochondria where they are completely chain shortened in 
series of mitochondrial β-oxidation steps (Tocher 2003). Mitochondrial 
β-oxidation is an important source of energy for several tissues including liver, 
heart and red muscles (Frøyland et al. 2000) and provides acetyl-CoA to enter 
the tricarboxylic acid (TCA) cycle (Tran & Christophersen 2001; 2002).  
 
Fatty acids need to be transported into the organelle and activated by conversion 
to fatty acyl-CoA thioesters with acyl-CoA synthetase before they enter the 
peroxisomal β-oxidation spiral (Schulz 2002) and mitochondrial β-oxidation 
spiral (Figure 1). In mitochondrial β-oxidation system, acyl-CoA is 
dehydrogenated to 2-trans-enoyl-CoA. Then enoyl-CoA hydratase catalyze the 
hydration of 2-trans-enoyl-CoA to L-3-hydroxyacyl-CoA, further the 
NAD
+
-dependent dehydrogenation of L-3-hydroxyacyl-CoA to 3-ketoacyl-CoA. 
Finally, 3-ketoacyl-CoA is cleaved by thiolase forming acetyl-CoA (Schulz 
2002). 
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Fatty acyl-CoA thioesters oxidized in peroxisomal β-oxidation also go through 
successive steps of dehydrogenation, hydration and thiolytic cleavage, the same 
as mitochondrial β-oxidation system (described above) except for the first step 
of dehydrogenation. In contrast to mitochondrial β-oxidation, the first 
dehydrogenation step involves the reduction of O2 to H2O2 by acyl-CoA oxidase 
(ACO), whereas in mitochondria, the first dehydrogenation step transfers two 
hydrogens from FAD to FADH2 (Lazarow & de Duve 1976). 
 
 
Figure 1: Overview of β-oxidation in mitochondria and the peroxisomes (Veiga et al. 2012). 
(1) acyl-CoA ligase; (2) ACO and peroxisomal acyl-CoA dehydrogenase; (3a) enoyl-CoA 
hydratase activity of multifunctional enzyme; (3b) 3-hydroxacyl: CoA dehydrogenase 
activity of multifunctional enzyme; (4) peroxisomal 3-keto-acyl-CoA thiolase; (5) 
mitochondrial acyl-CoA dehydrogenase; (6) enoyl: CoA hydratase; (7) 3-hydroxyacyl: 
CoAdehydrogenase; (8) mitochondrial3-ketoacyl-CoAthiolase. 
 
Peroxisomal β-oxidation is also found in the biosynthesis pathway of HUFA. 
DHA is formed from tetracosahexaenoic acid (24:6 n-3) by one round of 
β-oxidation (Ferdinandusse et al. 2001). ACO are enzymes that catalyze the 
rate-limiting step in peroxisomal β-oxidation, the dehydrogenation step 
involving the reduction of O2 to H2O2. ACO determine the substrate selectivity 
and capacities for β-oxidation (Crockett et al. 1993b). 
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2.4 Desaturases and desaturation 
The lipid composition of organisms not only depends on the dietary lipid 
ingested, but also on the ability of tissues or organs to synthesise or transform 
these lipids through desaturation and elongation pathways (Clandinin et al. 1983; 
Holman 1986; Lands 1991).  
 
Desaturases are enzymes that introduce unsaturated bonds (predominantly of 
the cis configuration) to a fatty acid chain. They do this by removing two 
hydrogen atoms (reviewed by Pereira et al. 2003). These enzymes are found 
almost universally in most living cells, where they help regulate the fluidity of 
membrane lipids, and also play a critical role in the biosynthesis of PUFAs 
(reviewed by Pereira et al. 2003). The desaturation reaction occurs in the 
endoplasmic reticulum of cells of particular tissues (Brenner 1974). 
Desaturation of fatty acids in fish is an aerobic process, it requires fatty acids 
esterified to CoA as substrate. Desaturases catalyze the removal of two 
hydrogen atoms and release a pair of electrons from the substrate. 
Simultaneously, two molecular water are produced by molecular oxygen and 
two pair of electrons (one pair of electrons obtained from NAD(P)H and 
transport by a short electron transport chain) (Brenner 1974). 
 
Three types of desaturases are found in animals, and named based on their 
desaturation site from the carboxyl end of the fatty acids chain; ∆9, ∆6 and ∆5. 
∆9 catalyzes synthesis of monounsaturated fatty acids. These enzymes introduce 
the first cis-double bond at the ∆9 position of the saturated fatty acid to 
synthesis monounsaturated fatty acids (Reviewed by Nakamura & Takayuki 
2004). These monounsaturated products formed (16:1 n-7 and 18:1 n-9) have 
markedly lower melting points than their saturated precursors (16:0 and 18:0) 
(Tocher 2010). Hence, ∆9 fatty acid desaturase provides a means of regulating 
the fluidity of cell membranes in response to changing temperature.  
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∆6fads and ∆5fads are required enzymes in the pathways for the biosynthesis of 
HUFA. ∆6fads and ∆5fads now have been isolated from Atlantic salmon 
(Hastings et al. 2004; Monroig 2010). ∆6fad introduce another double bond at 
the ∆6 position of the unsaturated fatty acid. According to the “Sprecher 
pathway” (Sprecher 2000) a Δ6fad catalyse the desaturation step involved in 
production of 22:5 n-6 from 20:4 n-6 and 22:6 n-3 from 20:5 n-3 (Figure 2). It is 
generally accepted that both the n-6 and n-3 fatty acids are metabolized by the 
same enzymes system (Sprecher 1981). Desaturases that introduce ethylenic 
bonds at five carbons from the carboxyl end of the molecule are termed ∆5. 
∆5fad add a double bond at the ∆5 position of 20:4 n-3 to produce 20:5 n-3. 
True marine fish are unable to produce DHA at a physiologically significant rate, 
and this has been attributed to the lack of ∆5fad activity in some species, such as 
sea bream (Tocher & Ghioni 1999). In the anadromous Atlantic salmon, both 
∆6fad and ∆5fad genes were highly expressed in intestine, liver and brain of 
salmon (Zheng et al. 2005a).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: A simplified scheme showing the biosynthesis of HUFA, indicating pathways of 
elongation and desaturation (Nakamura & Nara 2004). 
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As mentioned above, it is generally accepted that both the n-6 and n-3 fatty 
acids are metabolized by the same enzymes system (Sprecher 1981), however 
the ∆6fad appear to have a preference for longer fatty acid chains and a higher 
level of unsaturation (Sargent et al. 1993). Therefore, the affinity for the ∆6fad 
is in the order 18:1 n-9 < 18:2 n-6 < 18:3 n-3. The 18:3 n-3 fatty acid could also 
compete with 24:5 n-3 for the Δ6fad (Ruyter & Thomassen 1999). Thus, the 
20:5 n-3 can be converted to 24:5 n-3, which inhibit the desaturation of 18:3 n-3 
for the Δ6fad (Ruyter & Thomassen 1999). 
2.5 Elongase and elongation 
In addition to desaturation, the synthesis of HUFA involves enzyme-mediated 
fatty acyl elongation. Synthesis of EPA is achieved by Δ6 desaturation of 18:3 
n-3 to produce 18:4 n-3 that is elongated to 20:4 n-3 followed by Δ5 
desaturation (Cook 1996). Synthesis of DHA from EPA has been suggested to 
precede via a C24 intermediate, requiring two successive elongations to 22:5 
n-3 and then 24:5 n-3 (Sprecher et al. 1995). 
 
In the HUFA biosynthetic pathway, the fatty acids are elongated into very long 
chain fatty acids in a four-step reaction cycle by membrane-bound enzymes 
(Jakobsson et al. 2006). The reaction process begins with the condensation of a 
long chain acyl-CoA molecule with malonyl-CoA (provides 2-carbon units), 
resulting in β-ketoacyl-CoA. Subsequent reactions include reduction to 
β-hydroxyacyl-CoA, dehydration to an enoyl-CoA, and a second reduction to 
yield the elongated acyl-CoA (Jakobsson et al. 2006). 
 
The first step involves condensation of malonyl-CoA with acyl-CoA to yield 
carbon dioxide and a β-ketoacyl-CoA in which the acyl moiety has been 
elongated by two carbon atoms. The initial condensation reaction catalyzed by 
β-ketoacyl-CoA synthase is not only the substrate-specific step but also the rate 
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limiting step. 
 
Very long chain fatty acyl elongases (Elovl) are believed to perform the first 
step (condensation) in the elongation cycle (Jakobsson et al. 2006). Two fatty 
acid elongases termed Elovl5 and Elovl2 are characterized as important 
enzymes in the biosynthesis of PUFAs in higher vertebrates (Leonard et al. 
2004; Jakobsson et al. 2006). Gene sequences for similar elongase-like 
enzymes (Elovl2 and Elovl5) have recently been cloned from Atlantic salmon 
(Morais et al. 2009). Elovl are suggested to determine the substrate specificity 
and are the rate-limiting step in the elongation cycle (Jakobsson et al. 2006). 
Functional studies suggest that Elovl2 and Elovl5 have a substrate preference 
for PUFA. The Elovl5 is mainly involved in the elongation of C18-C20 
PUFAs, while Elovl2 elongates C20-22 HUFAs, but not C18 PUFAs 
(Leonard et al. 2002).  
2.6 Dietary fatty acids influence the HUFA biosynthesis 
Animals in general lack the ∆12fads and ∆15fads, which are required for the 
production of linoleic acid (18:2 n-6) and α-linolenic acid (18:3 n-3). As 
mentioned earlier, these fatty acids are considered to be essential and must be 
derived from the diet (reviewed by Pereira et al. 2003). Thus the dietary lipid 
composition may modulate the ability of species to desaturate fatty acids in 
order to adjust and maintain the n-3 HUFA content in tissues (Brenner 1981a; 
b; Buzzi et al. 1996; Tocher et al. 1997).There is currently been considerable 
interest in the nutritional regulation of ∆6fad gene expression and its activity, 
with the aim of determining which of the fatty acids in vegetable oils that can 
be utilized to substitute fish oil (Mourente & Dick 2002; Sargent et al. 2002). 
Although the detailed mechanisms behind regulation of the desaturases and 
elongases is not clear, the activity of the desaturation/elongation pathway is 
increased when Atlantic salmon are fed high levels of vegetable oils rich in 
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C18 fatty acids compared to salmon fed n-3 HUFA (Zheng et al. 2005b). 
Higher Δ6fad mRNA levels were measured in the liver and red muscle of 
Atlantic salmon fed diets in which 75 % of fish oil had been replaced by a 
blend of rapeseed, palm, and linseed oils in a 3.7:2:1 ratio compared to fish 
fed HUFA-rich diets containing only fish oil as a lipid source (Zheng et al. 
2005a; b). It has also been suggested that an increase in n-3 HUFA and 
reduced HUFA substrate levels may have a feedback inhibition effects on 
enzymes of fatty acid desaturation in the liver (Tocher et al. 2003; Thomassen 
et al. 2012). Altered dietary fatty acid composition possibly directly affects 
gene expression. The changes in gene expression may lead to altered activity 
of the HUFA biosynthetic pathway, and further also result in changes in tissue 
fatty acid composition. 
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3. Materials and methods 
3.1 Materials 
Table 1: Chemicals and equipment 
Chemicals and equipment Producer 
PureLink™ Pro 96 RNA Purification Kit Invitrogen, CA, USA 
AffinityScript QPCR cDNA Synthesis Kit Agilent Technologies, CA, USA 
Radio-labelled 18:3 n-3 American Radio-labelled Chemicals, St. Louis, USA  
Ethylene glycol tetra-acetic acid (EGTA) AppliChem, Darmstadt, Germany 
Hewlett Packard 6890 gas-liquid chromatograph 
(GC) 
Avondale, PA, USA 
Precellys 24  Bertin Technologies, Montigny-le-Bretonneux, France 
SPECTROstar Nano  BMG LABTECH,Ortenberg, Germany 
Kontes Pellet Pestle  Daigger, IL, USA 
scintillation fluid Ecoscint A, GA, USA 
Leibovitz's L-15 medium Gibco Life Technologies, MD, USA 
Primers Invitrogen Ltd, Paisley, UK 
DNaseI Invitrogen, Auckland, NZ 
Triton-X 100 Merck, Darmstadt, Germany 
Sodium chloride (NaCl) Merck, Darmstadt, Germany 
Benzene Merck, Darmstadt, Germany 
Hexane Merck, Darmstadt, Germany 
NanoDrop 1000 Spectrophotometer NanoDrop Technologies, DE, USA 
Six-well cell culture plates Nunc™, Denmark 
TRI-CARB 1900 TR scintillation counter Packard Instrument, IL, USA 
RNeasy® Mini Kit Qiagen, Valencia, CA, USA 
Radio-active flow detector A100 Radio-matic Instruments & Chemicals, FL. USA 
SYBR Green-I Master Roche Applied Science, Germany 
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Light Cycler 480 Roche Diagnostics Gmbh, Germany 
ID-BP × 70 column SGE, Melbourne, Australia 
Non radio-labelled DHA Sigma, St. Louis, USA 
Non radio-labelled OA Sigma, St. Louis, USA 
Total Protein Kit Sigma, St. Louis, USA 
Sucrose Sigma, St. Louis, USA 
HEPES Sigma, St. Louis, USA 
Foetal bovine serum (FBS) Sigma, St. Louis, USA 
Glutamine Sigma, St. Louis, USA 
Trypan blue Sigma, St. Louis, USA 
Penicillin Sigma, St. Louis, USA 
Streptomycin Sigma, St. Louis, USA 
Bovine serum albumin (BSA) Sigma, St. Louis, USA 
Phosphate buffer saline (PBS) Sigma, St. Louis, USA 
Ethylene diamine tetra-acetic acid (EDTA) Sigma, St. Louis, USA 
Sodium hydroxide (NaOH) Sigma, St. Louis, USA 
Flavin adenine dinuleotide (FAD) Sigma, St. Louis, USA 
Peroxidase Sigma, St. Louis, USA 
2’,7’-dichlorofluorescine Sigma, St. Louis, USA 
Dimethoxypropane Sigma, St. Louis, USA 
Palmitoyl CoA Sigma, St. Louis, USA 
96-well EIA/RIA plates  Sigma, St. Louis, USA 
Tris base Sigma, St. Louis, USA 
Hydrochloric acid (HCl) Sigma, St. Louis, USA 
Laminin Sigma, St. Louis, USA  
Dithiothreitol (DTT)  Sigma, St. Louis, USA 
Chloroform VWR International, PA, USA 
Methanol VWR International, PA, USA 
Collagenase type 1  Worthington Biochemical CLS, N.J., USA 
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3.2 In vivo study 
3.2.1 Fish and experimental design 
Fish for this in vivo study were obtained from Salmo Breed. Liver samples were 
selected from 1044 salmon from 103 families, ca 10 fish per family. Fish were 
anaesthetized with metacain (MS-222) and their weights and lengths determined. 
They were killed with a blow to the head, and the livers were removed from fish 
and stored at - 70 °C.  
 
The liver samples (1044 samples) were used for analysis of the level of ∆6fad_b 
gene expression. From the result of the ∆6fad_b gene expression, salmon 
families were selected as “high expression families” or “low expression 
families”. Further, from this 60 fish were selected for ACO measurement and 
ACO gene expression (30 fish from “high expression families” and 30 fish from 
“low expression families”, 5 families from each group, 6 fish per family). And 
from this 60 fish of similar weight were selected for fatty acid composition 
analysis and comparing ∆6fad_b expression between high and low∆6fad_b 
expression families. 
3.2.2 Tissue RNA isolation  
Total RNA from salmon liver tissue was isolated using PureLink™ Pro 96 RNA 
Purification Kit. This kit enables isolation of RNA from 96 samples in one plate. 
Approximately 30 mg liver tissue were homogenized in 800 μl PureLink™ Pro 
96 Lysis Buffer using Precellys 24 for 2 × 20 seconds with a break at 5000 rpm. 
The samples were centrifuged at 2600 × g for 10 minutes. Thereafter, 250 μl of 
the supernatant was added 250 μl 70 % ethanol and transferred to a to a filter 
plate. The plate was centrifuged at 2100 × g, for 3 minutes at room temperature. 
500 μl wash buffer was added and the plate centrifuged again at 2100 × g for 3 
minutes at room temperature. RNA attached to the filter was treated with 
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DNaseI to remove genomic DNA by incubating with 80 μl DNaseI solution for 
15 minutes at room temperature. The plate was centrifuged at 2100 × g for 3 
minutes at room temperature. The RNA was washed twice by adding 700 μl 
wash buffer and centrifuged at 2100 × g for 3 minutes at room temperature. The 
second centrifugation was prolonged to 10 minutes. RNA was eluted by adding 
50 μl RNase-free water and centrifugation at 2100 × g for 3 minutes at room 
temperature. The RNA samples were kept at - 70 °C until analysis. 
3.2.3 RNA measurements 
Concentration and purity of RNA isolated from liver tissue were evaluated 
using NanoDrop 1000 Spectrophotometer. Nucleic acids absorb light mainly 
at wavelength 260 nm, proteins at 280 nm, therefore 260/280 is the most 
important ratio to value nucleic acid purity. 260/230 is a secondary evaluation 
of purity, since other contaminants absorb near 230 nm.  
3.2.4 Purification of RNA 
Some of the samples were purified by precipitation due to low 260/280 ratio. 
The RNA samples were added 0.1 volumes ethanol (100 %) and 3 volumes 
sodium acetate (3M, pH 4.8). After 30 minutes incubation at room 
temperature, the samples were centrifuged for 10 minutes at 4C at 10,000 × g. 
Thereafter the supernatant were removed and the pellets were dried for 10 
minutes. The RNA pellet was resolved in RNase-free water. 
3.2.5 cDNA synthesis 
cDNA was made from 500 ng RNA in a 10 μl reaction volume by using 
AffinityScript QPCR cDNA Synthesis Kit. RNA (500 ng) was added 
RNase-free water to a final volume of 3 μl. Thereafter 5 μl first strand master 
mix (2 ×), 1.5 μl oligodT and 0.5 μl AffinityScript RT/RNase Block enzyme 
mix was added. The cDNA synthesis was run in a polymerase chain reaction 
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(PCR) machine under the following conditions: 25C for 5 minutes to allow 
primer annealing, 42 C for 45 minutes to synthesize cDNA, and 95 C for 5 
minutes to terminate cDNA synthesis reaction. The cDNA was stored at - 20 
C until analysis. 
3.2.6 QPCR analysis 
The reaction mix for qPCR consisted of 4 μl diluted (1:10) cDNA, 0.5μl 
forward primer, 0.5 μl reverse primer (final concentration of 0.5 μM), and 5 μl 
SYBR Green-I Master. A standard curve was included for each primer pair to 
evaluate the primer efficiency. All samples were analysed in parallels. The 
qPCR reaction was run on a Light Cycler

480 under the following conditions: 
Preincubation at 95 C for 5 minutes, amplification with 45 cycles at 95 C for 
15 seconds and 60 C for 1 minutes, melting curve at 95 C for 5 seconds and 
65 C for 1 minutes, cooling at 40 C for 10 seconds. 
 
Table 2: Sequence of primes. All sequences are presented as 5’-3’ 
Gene Accession no. Direction Primer sequence 
Δ6fad_b GU207400 
Forward TGACCATGTGGAGAGTGAGGG 
Reverse AACTTTTGTAGTACGTGATTCCAGCT 
ACO DQ364432 
Forward CCTTCATTGTACCTCTCCGCA 
Reverse CATTTCAACCTCATCAAAGCCAA 
etif DW542195 
Forward CAGGATGTTGTTGCTGGATGGG 
Reverse ACCCAACTGGGCAGGTCAAGA 
 
3.2.7 Lipid extraction  
Total fat was extracted from liver tissue according to the Folch extraction 
(Folch et al. 1957). Approximately 60 mg liver tissue was homogenized in 50 
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ml chloroform/methanol (2:1, v/v) with butylated hydroxytoluene 2 mg/ml 
and 6 ml 0.9 % NaCl for 60 seconds with a knife homogenizator. The 
homogenized sample was added 6 ml 0.9 % NaCl and then homogenized for 5 
seconds. The homogenate was filtered by flowing through a cotton filter 
inside at funnel into a graded cylinder. The graded cylinder was capped in 
case of evaporation and kept in - 40 °C freezer to the next day. The methanol 
phase and protein was carefully removed, and 20 ml of the chloroform phase 
were transferred to a weighted beaker for measuring fat content. The 
remaining chloroform phase was stored at - 20 °C until fatty acid analysis. 
The chloroform phase in the beaker was dried at < 60 °C until the organic 
solvent evaporated and then transferred to oven at 102 °C for 30 minutes. The 
final weight of the beaker was subtracted from the start weight to get the total 
fat weight. The total fat content was calculated as: 
5.37
UI
100fat g
tfa %


 , g fat is 
total fat weight in beaker, I is the weight of sample in g, U is the volume of 
chloroform phase in the beaker in ml, 37.5 is total volume of chloroform 
solvent in ml. 
3.2.8 Fatty acid methylation 
The remaining chloroform phase stored at - 20 °C (described above) was 
thawed and chloroform was evaporated at 60 °C with nitrogen overflow. The 
residual lipid extract was trans-esterificated to fatty acid methyl esters (FAME) 
in 2 ml benzene, 2 ml metanolic-HCl and 0.2 ml dimetoxypropan, as 
described by Mason and Waller (1964). FAME was extracted and purified by 
using 2 ml hexan and neutralized by adding 4 ml 6 % NaHCO3. The upper 
phase containing the organic phase was transferred to a new glass vial and the 
organic solvent evaporated at 60 °C with nitrogen overflow. The dried lipid 
sample was then dissolved in 1 ml hexane prior to gas-liquid chromatography 
(GC) analysis. 
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3.2.9 Fatty acid composition 
FAME was analyzed by Hewlett Packard 6890 GC equipped with a ID-BP × 70 
column (60 m × 0.25 mm i.d., 0.25 μm film thickness). FAME was introduced 
by split injection (50:1) at 300 °C. Helium was used as carrier gas and 
temperature was 50 °C for 1.2 minutes, increased from 50 °C to 170 °C at 
4 °C/minute, and increased to 200 °C at 0.5 °C/minute, then to 300 °C at 
10 °C/minute. Separated fatty acid composition was detected by flame 
ionization detector (FID) at 300 °C. Peak integration was performed using HP 
Chem Station software. The relative quantity of each fatty acid present was 
determined by measuring the area of the peak corresponding to a particular fatty 
acid, and then identification of major peaks was made by comparing the 
retention times with those of fatty acid methyl ester standards of GLC-85. 
3.2.10 Determination of peroxisomal β-oxidation: ACO activity 
Approximately 50 mg liver tissue was homogenized in 250 μl homogenization 
buffer(0.25 M sucrose, 15 mM HEPES, 1.0 mM EDTA and 1.0 mM EGTA) 
using Kontes Pellet Pestle. The samples were diluted by using equal amount 
of 0.4 % Triton-X 100 and then centrifuge at 800 × g for 15 minutes at 4 °C. 
 
Spectrophotometric assay of ACO was determined by measuring production 
of H2O2, which was coupled to oxidation of 2’, 7’-dichlorofluorescine in a 
reaction catalyzed by peroxidase (Small et al., 1985). The reaction mixture 
contained 0.5 M Tris (pH 8.5), 60 mg/ml bovine serum albumin (BSA), 9.8 μg 
peroxidase, 0.05 M 2’, 7’-dichlorofluorescine, 1.5 mM FAD. Prepared 
samples were added to this mixture, and then 6 mM palmitoyl-CoA was used 
to start the reaction. 2’, 7’-dichlorofluorescine and FAD were prepared daily 
and protected from light. The reaction was performed in 96-well EIA/RIA 
plates and measured with SPECTROstar Nano at 502 nm for 180 seconds at 
room temperature. Results were corrected by substrate blank. 
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The ACO activity was calculated as: 
1000D
Ve
Vt
d)cm(mM 260
/minΔA
ml)min /  / (nmolactivity ACO
11
502 



 
∆A502 is the increasing absorbance during 3 minutes at 502 nm, 260.6 (mM
-1
 × 
cm
-1
) is extinction coefficient of 2’, 7’-dichlorofluorescine at 502 nm, d is the 
diameter of reaction well in cm, Vt is the total reaction volume in ml, Ve is the 
enzyme sample volume in ml, D is the dilution factor of the enzyme sample.  
 
The activities per mg of protein (specific activity) in liver homogenates were 
calculated as: 
 
(mg/ml) sample enzymein protein  ofion Concentrat
ml)min/ (nmol/ Activity  ACO
  protein) mgmin/ (nmol/ Activity  ACO 
 
The activities per g of liver (nmol / min / g liver) were calculated as:  
 
W
V ml)min/ (nmol/ Activity  ACO
  liver) gmin/ (nmol/ Activity  ACO

  
 
W is the weight of tissue sample in g, V is the volume of homogenization buffer 
in ml. 
3.2.11 Protein measurements 
Protein concentration in the liver tissue homogenates was measured by using a 
total protein kit (Micro Lowery/ Peterson’s modification), which rely on the 
method of Lowry et al. (1951) and modified by Peterson (1977). Standards 
(BSA) were prepared by diluting 400 μg/ml of BSA in water. Sodium chloride 
was added to a concentration of 0.1 M to eliminate interference, then 0.15 % 
DOC and 72 % TCA were added to precipitate proteins. Precipitated proteins 
were resolved in Lowry reagent solution and added Folin and Ciocalteu’s 
Phenol Reagent. Absorbance of the colored solution was read with 
SPECTROstar Nano at 500 nm. 
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3.3 In vitro study 
3.3.1 Isolation of hepatocytes  
Two experimental fish, Atlantic salmon (of approximately 300 g), were used for 
isolation of hepatocytes. The fish came from fish lab of Norwegian University 
of life sciences. Fish were anaesthetized with 2 g/l metacain (MS-222), and then 
0.1 ml heparin (5000 IU/ml) was inserted into the back vein to inhibit 
thrombosis. The hepatocytes were prepared by a two step collagenase perfusion 
procedure described by Seglen (1976) and modified by Dannevig and Berg 
(1985). Briefly, after the abdominal cavity was exposed, aportal cannula was 
inserted into the portal vein on the underside of the liver. The heart was cut open, 
so that the perfusion liquid from the liver could be transported out. The liver 
was perfused with EDTA perfusion solution (25 mM EDTA, 143 mM NaCl and 
6.7 mM KCl) for approximately 10 minutes until most of the blood was 
removed from the liver. Further, the liver was perfused with a collagenase 
solution which contained 143 mM NaCl, 6.7 mM KCl, 1 mM CaCl2 and 0.1 % 
collagenase type 1 (125-200 U/mg) for approximately 20 minutes. The liver was 
then transferred into Leibovitz's L-15 mediumand gently shaken until cells were 
loosen. The suspension of cells was filtered through a 100 μm nylon filter, then 
washed two times in L-15 medium and collected by centrifugation at 800 × g 
for 2 minutes. The cells were resuspended in growth medium (L-15 medium 
containing 0.375 mg/ml bicarbonate, 2 mM glutamine, 10 mM HEPES, 50 U/ml 
penicillin, 50 μg/ml streptomycin and 10 % foetal bovine serum (FBS)). 100 μl 
0.4 % trypan blue was added to 100 μl cell suspension to assess cell viability 
and count them in a Burkes counting chamber. The cells were diluted in growth 
medium to 2 million cells/ml and seeded onto 20 laminin coated plates (Figure 3) 
and incubated at 13 °C to let the cells attach to the bottom.  
 
 
Materials and methods 
 
23 
 
 
 
 
 
 
 
Figure 3: Six-well cell culture plates (Latif 2010). 20 plates (total 120 wells) were used in 
this cell experiment.  
3.3.2 Incubation of hepatocytes with fatty acid 
The hepatocyte cultures were preincubated at 13 °C for 24 hours prior to 
initiation of the experimental conditions. Hepatocytes at a density of ca. 5 × 
10
5
 cells/cm
2
 were incubated with OA and DHA in different ratios. 
Specifically, the four fatty acid combination were 100 μM OA, 25 μM OA/75 
μM DHA, 75 μM OA/25 μM DHA and 100 μM DHA. Each fatty acid 
combination treatment was performed in 25 wells. In addition 20 wells got a 
control treatment, added albumin (0.12 g/ml) instead of fatty acid. The fatty 
acids OA and DHA were added to the medium in the form of their potassium 
salts bound to BSA (2.7/1, molar ratio). Briefly, 25 mg fatty acid was 
dissolved in 1 ml chloroform (to 76 mM) and evaporated under a stream of 
nitrogen at 50-60 C or 37-40 C (OA at 50-60 C and DHA at 37-40 C). 3 
ml of 0.1 M preheated NaOH was slowly added. The fatty acid-NaOH 
solution was then transferred to 12 ml preheated phosphate-buffered saline 
(PBS)-albumin which contained 1.88 g albumin. The Fatty acids on albumin 
were adjusted to pH = 7. The fatty acids were added to the L-15 medium 
containing 0.375 mg/ml bicarbonate, 10 mM HEPES, 1 % 
penicillin-streptomycin and 10 % FBS. The incubation was performed with a 
final concentration of 100 µM of Fatty acids at 13 °C for 66 hours. The cells 
for gene expression were washed two times in PBS and harvested in 
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QIA-shredder columns. The cells for ACO activity measurement and fatty 
acid analysis were washed two times in PBS with 1 % albumin, and one time 
in PBS, and harvested in 1 ml PBS and stored at - 70 C. 
3.3.3 RNA isolation 
RNA isolation from hepatocytes was carried out by using an RNeasy
®
 Mini 
Kit. The cells were lysed in 350 μl RLT buffer with 0.04 M DTT in 
multiwell-plates. The lysate were homogenized by pipetting the lysate into 
QIA shredder columns and centrifuged at 13000 rpm for 2 minutes. The upper 
parts of the columns were taken away and the suspension were added 350 μl 
70 % ethanol to provide appropriate binding conditions for the total RNA to 
bind to the RNeasy silica membrane when the samples were transferred to 
RNeasy columns and centrifuged at 13000 rpm for 15 seconds. Thereafter, the 
samples were incubated in 80 μl DNase mix (10 μl Dnase I + 70 μl RDD 
buffer) for 15 minutes at room temperature to remove the DNA in the samples. 
Then the DNasewas eliminated by a second wash with Buffer RW1. 
Contaminants in the samples were efficiently washed away in 500 μl RPE 
buffer with ethanol and centrifuged at 13000 rpm for 15 seconds. 40 μl RNase 
free water was added to the RNA and centrifuged at 13000 rpm for 1 minute 
to elute RNA. After RNA isolation, the total RNA concentrations were 
determined by spectrophotometry (NanoDrop 1000 Spectrophotometer). 
3.3.4 ACO activity analysis 
Approximately 20 μl hepatocytes in 180 μl PBS was homogenized using 
Kontes Pellet Pestle. The samples were diluted by using equal amount of 0.4 % 
Triton-X 100 and then centrifuge at 800 × g for 15 minutes at 4 °C.  
 
Spectrophotometric assay of ACO in hepatocytes was determined by 
measuring production of H2O2, which was coupled to oxidation of 2’, 
7’-dichlorofluorescine in a reaction catalyzed by peroxidase (Small et al. 
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1985). Prepared 20 μl samples were added to the reaction mixture (described 
in ACO measurement in vivo study), and then 6 mM palmitoyl-CoA was used 
to start the reaction. The reaction was performed in 96-well EIA/RIA plates 
and measured with SPECTROstar Nano at 502 nm for 180 seconds at room 
temperature. The ACO activity was calculated as described above (ACO 
measurement in vivo study). 
3.3.5 Lipid extraction and analysis of fatty acid composition 
Total lipid was extracted from cell pellets according to Folch et al. (1957) using 
chloroform/methanol (2:1, v/v) containing 0.03 % butylated hydroxytoluene. 
0.9 % NaCl was added in two rounds, to get the volume ratio of chloroform, 
methanol and water in solution to approximately 8:4:3. Following mixing and 
separation of the phases by centrifugation at 3000 rpm for 10 minutes at 4 °C, 
the chloroform layer was pipetted off and dried under nitrogen before being 
redissolved in chloroform/ methanol (2:1, v/v) containing 0.03 % butylated 
hydroxytoluene. 
 
The chloroform phase was dried under nitrogen and trans-methylated 
overnight with 2 ml benzene, 2 ml metanolic-HCl and 0.2 ml dimetoxypropan 
as described by Mason and Waller (1964). Next day, FAME was extracted and 
purified by using 2 ml hexan neutralized by adding 4 ml 6 % NaHCO3. The 
FAME was separated according to degree of unsaturation and chain length by 
GC and the fatty acids were identified and calculated as described above. 
3.3.6 Incubation with radio-labelled fatty acids 
After stimulation of hepatocytes with OA and DHA, the cells for β-oxidation 
and metabolism were washed two times in PBS with 1 % albumin, and one time 
in L-15. Further hepatocytes at density of ca. 5 × 10
5
 cells/cm
2
 were incubated 
with 7 μM (final concentration) radio-labelled 18:3 n-3 ([1-14C] 18:3 n-3). The 
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radio-labelled fatty acid was added to the medium in the form of its potassium 
salt bound to BSA, prepared as described above. 20 wells (5 wells from each 
OA/DHA treatment) were incubated with this isotope at 13 °C for 24 hours in 
2.5 ml L-15 medium (containing 0.375 mg/ml bicarbonate, 10 mM HEPES, 1 % 
penicillin-streptomycin) without FBS. 
 
After incubation with [1-
14
C] 18:3 n-3 for 24 hours, the media were harvested 
for measuring β-Oxidation, the cells were washed in PBS with 1 % albumin and 
in PBS without albumin and then were harvested in 1 ml of PBS for analysis of 
elongation and desaturation products by high-pressure liquid chromatography 
(HPLC). 
3.3.7 β-Oxidation 
The capacity of β-oxidation was measured by determination of the 
radio-labelled products, acid soluble products (ASP) and CO2 as described by 
Christiansen et al. (1976).  
 
The production of CO2 was measured by transferring 1.4 ml of the medium to 
glass vials sealed with a rubber stop and a central well containing a filter paper. 
CO2 released from the acidified medium by addition of 0.3 ml 1 M HClO4 to 
the trap flasks, was trapped by injecting 0.3 ml phenylethylamine/methanol 
(1:1 v/v) to the filter paper for 1 hour at room temperature. Then the filter 
papers were placed in vials and added 10 ml of scintillation fluid for 
scintillation counting.  
 
The amount of radio-labelled ASP was determined by adding 0.5 ml ice cold 2 
M HClO4 to 1 ml cell media and incubated on ice for 1 hour,  then the 
samples were centrifuged at maximum speed for 10 minutes at 4 °C and 100 
μl of the supernatant was collected for scintillation counting. A standard curve 
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were prepared by measuring radio-activity in 0 μl, 5 μl, 10 μl, 20 μl, 40 μl, 80 
μl, respectively, of the [1-14C] 18:3 n-3 fatty acids. 
3.3.8 High-pressure liquid chromatography (HPLC) 
After total lipid was extracted from cells as described above, 50 μl of the 
chloroform phase was transferred into scintillation vials containing 5 ml of 
scintillation fluid to measure radio-activity in an aliquot of the total lipid with 
a TRI-CARB 1900 TR scintillation counter. Results were corrected for 
counting efficiency and quenching of 
14
C under exactly these conditions. The 
rest of chloroform phase was dried under nitrogen. 
 
FAMEs were prepared as above which is then analyzed in high-pressure liquid 
chromatography as described by Narce et al. (1988). The mobile phase was 
acetonitrile/H2O (85:15 by volume) at 30 °C and with flow rate 1 ml/minute. 
The column used was a reversed-phase Symmetry 3.5 µm C18 HPLC column 
from Waters was used. Radio-activity level in the different fatty acids was 
measured in a radio-active flow detector A100. The radio-active fatty acids were 
identified by comparing the retention time of samples with the retention 
volumes of known fatty acid standards. 
3.4 Statistical analysis 
For all data in the in vivo study, except for gene expression and correlation, 
the independent t-test in SPSS (IL, USA) was used. Correlation between DHA 
+ EPA and fat content (or body weight) was analyzed by Pearson correlations, 
followed two-tailed test to determine significant differences. All data in the in 
vitro study were subjected to one-way ANOVA for the factor “treatment” 
(ratio of OA/DHA), and differences were ranked by Ducan’s multiple range 
test. We used the software package UNISTAT (London, England). The 
significance level was set to P ≤ 0.05. 
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4. Results 
4.1 In vivo trial 
4.1.1 ∆6fad_b gene expression in liver tissue from fish in different families 
Screening 103 families for their expression of the ∆6fad_b gene showed that 
the levels of ∆6fad_b gene expression were greatly different between the 
families. The family with the highest expression had almost 25 times higher 
expression of the gene than the family with the lowest expression (Figure 4).  
Results 
 
29 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
F
ig
u
re
 4
: 
R
el
at
iv
e 
g
en
e 
ex
p
re
ss
io
n
s 
o
f 
∆
6
fa
d
_
b
 i
n
 s
al
m
o
n
 l
iv
er
. 
T
h
e 
g
en
e 
ex
p
re
ss
io
n
 o
f 
∆
6
fa
d
_
b
 i
s 
n
o
rm
al
iz
ed
 t
o
 t
h
e 
re
fe
re
n
ce
 g
en
e 
et
if
. 
T
h
e 
v
al
u
es
 
ar
e 
ex
p
re
ss
ed
 a
s 
th
e 
m
ea
n
 o
f 
al
l 
fi
sh
 i
n
 e
ac
h
 f
am
il
y
 a
n
d
 w
it
h
 ±
 S
E
M
. 
 
  
Results 
 
30 
 
When comparing the ∆6fad_b gene expression level in fish with similar 
weight  from the families selected as “high expression families” and “low 
expression families”, we could see that the relative gene expression of “high 
expression families” were about thirteen fold higher than “low expression 
families” (Figure 5).  
 
Figure 5: Relative gene expression level of ∆6fad_b in liver of the “high expression 
families” and “low expression families”. The gene expression of ∆6fad_b is normalized 
to the reference gene etif. Data are means ± SEM (n = 14 for high expression families, n 
= 16 for low expression families). Different letters indicate statistical differences (P ≤ 
0.05). 
4.1.2 Correlation between the percentage of DHA + EPA and fat content in liver 
tissue  
Percentages of DHA + EPA of total fatty acids in salmon liver tissue showed a 
strong linear relationship with fat content in liver tissue, decreasing with 
increasing fat content (Figure 6). This clear negative relationship was found in 
both “high expression families” and “low expression families”.  
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Figure 6: Correlation between DHA + EPA (percent of total fatty acids) and fat content (% 
fat) in salmon liver of the “high expression families” and the “low expression families”. 
Liver samples analyzed from 5 fish in each family. 
 
The ratio DHA + EPA / fat content in the families with high expression were 
about 30 % higher than in the families with low expression (Figure 7), 
however this was not statistically significant. 
 
 
Figure 7: The ratio of DHA+EPA (percent of total fatty acids) / fat content (% fat) in the 
“high expression families” and the “low expression families”. Data are means ± SEM (n 
= 14 for high expression families, n = 16 for low expression families). Different letters 
indicate significant differences (P ≤ 0.05). 
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4.1.3 Correlation between the percentage of DHA + EPA and body weight of 
fish 
Percentages of DHA + EPA of total fatty acids in “high expression families” 
showed a negative correlation with individual fish weight, decreasing with 
increasing weight (Figure 8). However, no correlation was found between 
individual weight of fish and percentages of DHA + EPA in “low expression 
families”. 
 
Figure 8: Correlation between DHA + EPA (percent of total fatty acids) and body weight 
(g) of the “high expression families” and the “low expression families”. Liver samples 
analyzed from 5 fish in each family. 
4.1.4 Fatty acid compositions in liver tissue from fish in different families 
Fatty acid compositions in liver tissue of the “high expression families” and 
“low expression families” are shown in Table 3. The levels of the n-3 long 
chain fatty acid DHA and EPA were slightly higher in “high expression 
families” than “low expression families”, although not significant. In addition, 
the livers from fish of the “high expression families” contained significantly 
higher of ∑saturated fatty acids than the fish of the “low expression families”. 
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Table 3: Comparison of fatty acid compositions of livers in similar body weight salmon 
between “high expression families” and “low expression families”. The quantity of each 
fatty acid is given in percent of total fatty acids. Data are means ± SEM (n = 14, 16). 
Different letters indicate significant differences (P ≤ 0.05). 
Fatty acids (% of total) High expression families Low expression families 
C 14:0 2.5 ± 0.07a 2.2 ± 0.05b 
C 16:0   9.0 ± 0.40 7.9 ± 0.27 
C 18:0 3.8 ± 0.16 3.3 ± 0.14 
∑ Saturated 15.3 ± 0.53
a 13.4 ± 0.36b 
C 16:1 n-7 2.7 ± 0.10 2.7 ± 0.13 
C 18:1 n-7 3.0 ± 0.03 2.8 ± 0.13 
C 18:1 n-9 30.0 ± 0.79 31.1 ± 0.78 
C 18:1 n-11 1.9 ± 0.14 1.9 ± 0.10 
C 22:1 n-7 1.8 ± 0.04 1.8 ± 0.04 
C 20:1 n-9    5.9 ± 0.18 6.3 ± 0.12 
C 22:1 n-9 0.5 ± 0.02 0.5 ± 0.02 
C 22:1 n-11 2.9 ± 0.09 3.0 ± 0.11 
∑ Monounsaturated 48.7 ± 1.11 49.3 ± 0.98 
C 18:2 n-6 7.7 ± 0.16 7.9 ± 0.12 
C 18:3 n-3 2.7 ± 0.06 2.8 ± 0.06 
C 20:4 n-3 1.4 ± 0.05 1.4 ± 0.05 
C 20:2 n-6 1.6 ± 0.06 1.7 ± 0.04 
C 20:4 n-6 0.8 ± 0.05 0.8 ± 0.06 
C 20:5 n-3 4.6 ± 0.21 4.5 ± 0.22 
C 22:5 n-3 1.6 ± 0.08 1.8 ± 0.07 
C 22:6 n-3 10.5 ± 0.64 10.3 ± 0.61 
∑ Polyunsaturated 31.0 ± 0.69 31.5 ± 0.76 
∑ n-3 20.7 ± 0.79 20.8 ± 0.78 
∑ n-6 10.0 ± 0.16 10.5 ± 0.13 
EPA + DHA 15.0 ± 0.84 14.8 ± 0.82 
4.1.5 ACO activity in liver tissue from fish in different families 
The ACO activity was not significantly different between the “high expression 
families” and the “low expression families”, being 17.93 ± 1.20 nmol × min-1 
× g
-1
 liver and 16.56 ± 1.22 nmol × min
-1 
× g
-1
 liver respectively (Figure 9). 
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Figure 9: ACO activity in salmon liver tissue of the “high expression families” and “low 
expression families”. The results is displayed here as nmol/min/g liver tissue. Data are 
presented as means ± SEM. Different letters indicate significant differences (P ≤ 0.05). 
4.1.6 ACO gene expression in liver tissue from fish in different families 
The ACO gene expression was not significantly different between the “high 
expression families” and the “low expression families”, being -0,68 ± 0.33 
and -0,61 ± 0.23 respectively (Figure 10).  
 
 
 
 
 
 
 
 
Figure 10: Relative gene expression level of ACO in liver of the “high expression 
families” and “low expression families”. The gene expression of ACO is normalized to 
the reference gene etif. Data are means ± SEM. Liver samples analyzed from 5 fish in 
each family. Different letters indicate statistical differences (P ≤ 0.05). 
0 
5 
10 
15 
20 
25 
 High expression family Low expression family 
n
m
o
l×
m
in
-1
×g
-1
 li
ve
r 
ACO activity 
High expression 
family 
Low expression 
family 
-2 
-1.5 
-1 
-0.5 
0 
R
e
la
ti
ve
 g
e
n
e
 e
xp
re
ss
io
n
 
ACO gene expression 
Results 
 
35 
 
4.2 In vitro trial 
4.2.1 Fatty acid compositions in hepatocytes 
The fatty acid compositions in hepatocytes (Table 4) reflected the ratio of OA 
and DHA given to the hepatocytes. Incubation of hepatocytes with increased 
level of OA led to increased intracellular level of OA and its elongation 
product 20:1 n-9. The percentage of DHA in hepatocytes also increased with 
increasing level of this fatty acid supplemented in the cultivation media. The 
percentage of EPA and DHA increased from 17.5 % in the 100OA group to 
20 % in the 75OA/25DHA group and to approximately 22 % in 
25OA/75DHA and 100DHA groups. 
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Table 4: Fatty acid compositions in hepatocytes stimulated with OA and DHA. The 
quantity of each fatty acid is given in percent of total fatty acids. Data are means ± SEM 
(n = 5).  
  
  
100OA 75OA/25DHA 25OA/75DHA 100DHA 
C 14:0 1.11 ± 0.12 1.0 ± 0.04 1.1 ± 0.01 1.1 ± 0.02 
C 16:0   10.2 ± 0.37a 10.2 ± 0.08a 10.9 ± 0.05b 11.2 ± 0.13b 
C 18:0 5.2 ± 0.08a 5.1 ± 0.04a 5.5 ± 0.04b 5.5 ± 0.03b 
∑ Saturated 16.5 ± 0.55
a 16.4± 0.14a 17.4 ± 0.08b 17.8 ± 0.17b 
C 16:1 n-7 3.00 ± 0.05a 3.0 ± 0.04a 2.8 ± 0.06b 2.9 ± 0.06ab 
C 18:1 n-9 35.1 ± 0.24a 34.1 ± 0.11b 30.9 ± 0.06c 30.3 ± 0.26d 
C 18:1 n-7 2.9 ± 0.04a 2.9 ± 0.02a 2.9 ± 0.01a 3.0 ± 0.03b 
C 20:1 n-9    5.0 ± 0.07a 4.7 ± 0.02b 4.1 ± 0.02c 4.2 ± 0.09c 
C 22:1 n-7 0.5 ± 0.07  0.5 ± 0.02 0.6 ± 0.02 0.6 ± 0.02 
∑ Monounsaturated 46.5 ± 0.25
a 45.2 ± 0.16b 41.4 ± 0.12c 41.0 ± 0.38c 
C 18:2 n-6 6.7 ± 0.06 6.7 ± 0.03 6.8 ± 0.02 6.7 ± 0.10 
C 18:3 n-3 1.6 ± 0.04a 1.6± 0.00a 1.7 ± 0.02b 1.6 ± 0.04a 
C 20:2 n-6 1.7 ± 0.02a 1.8 ± 0.06b 1.8 ± 0.01b 1.9 ± 0.02b 
C 20:3 n-6 1.0 ± 0.02a 1.0 ± 0.01a 0.9 ± 0.02b 1.0 ± 0.03ab 
C 20:4 n-6 2.1 ± 0.05a 2.2 ± 0.03ab 2.3 ± 0.01b 2.2 ± 0.06ab 
C 20:3 n-3 0.4 ± 0.01a 0.5 ± 0.01b 0.5 ± 0.01b 0.5 ± 0.01b 
C 20:5 n-3 1.6 ± 0.01a 1.7 ± 0.01b 2.0 ± 0.02c 2.0 ± 0.02d 
C 22:5 n-3 0.8 ± 0.02a 0.8 ± 0.02a 1.0 ± 0.03b 1.0 ± 0.03b 
C 22:6 n-3 16.0 ± 0.28a 18.1 ± 0.09b 20.0 ± 0.07c 20.2 ± 0.26c 
∑ Polyunsaturated 32.0 ± 0.36
a 34.5 ± 0.14b 37.1 ± 0.11c 36.9 ± 0.27c 
Sum n-3 20.4 ± 0.29a 22.7 ± 0.10b 25.5 ± 0.09c 25.3 ± 0.26c 
Sum n-6 11.6 ± 0.08a 11.8 ± 0.07bc 11.9 ± 0.02c 11.7 ± 0.05ab 
EPA+DHA 17.5 ± 0.28
a 19.8 ± 0.10b 21.9 ± 0.06c 22.2 ± 0.28c 
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4.2.2 ACO activity in hepatocytes 
The ACO activity in hepatocytes incubated with fatty acid combinations are as 
show in Figure 11. The ACO activity was increased in response to increased 
proportion of DHA stimulation. Hepatocytes incubated with 75OA/25DHA 
had significantly lower ACO activity than hepatocytes incubated with 
100DHA. 
 
 
Figure 11: ACO activity in salmon hepatocytes. The hepatocytes were stimulated with 
one of four fatty acid combinations; 100OA, 75OA/25DHA, 25OA/and 100DHA. ACO 
activity is displayed as nmol/min per mg protein. Data are presented as means ± SEM (n 
= 5). Different letters indicate significant differences (P ≤ 0.05). 
4.2.3 ACO gene expression in hepatocytes  
The relative expression of the ACO gene is shown in Figure 12. The 
hepatocytes incubated with 25OA/75DHA had significantly lower expression 
of ACO than hepatocytes added 100DHA. The ACO gene expression showed 
a tendency to increase in response to increased proportion of DHA 
stimulation. 
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Figure 12: Relative gene expression of ACO in hepatocytes stimulated with one of four 
fatty acid combination; 100OA, 75OA/25DHA, 25OA/and 100DHA. The gene 
expression level of ACO is normalized to the gene expression of the reference gene etif. 
Data are presented as means ± SEM (n = 5). Different letters indicate significant 
differences (P ≤ 0.05). 
4.2.4 ∆6fad_b gene expression in hepatocytes 
The relative expression of ∆6fad_b is shown in Figure 13. The hepatocytes 
incubated with high proportion of OA had significantly higher expression of 
∆6fad_b than hepatocytes incubated with high proportion of DHA. 
 
 
 
 
 
Figure 13: Relative gene expression of ∆6fad_b in hepatocytes stimulated with one of 
four fatty acid combination; 100OA, 75OA/25DHA, 25OA/and 100DHA. The gene 
expression of ∆6fad_b is normalized to the reference gene etif. Data are presented as 
means ± SEM (n = 5). Different letters indicate significant differences (P ≤ 0.05). 
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4.2.5 Metabolism of [1-
14
C] 18:3 in hepatocytes 
Approximately 70 % of the added radio-labelled substrate was taken up by the 
cells, while approximately 30 % remained in the culture media. Table 5 show 
that there were no significant differences in the total nmol radio-labelled fatty 
acids taken up by the cells per mg protein between the different groups. More 
than 99 % of the fatty acids taken up were found in cellular lipids and less 
than 1 % was found in the β-oxidation product CO2.  
 
Table 5: Distribution of total nmol radio-activity in the cells and β-oxidation products, 
after incubation of hepatocytes with [1-
14
C] 18:3 n-3 for 24 hours. 
  
  
100OA 75OA/25DHA 25OA/75DHA 100DHA 
Total cellular uptake  
(nmol mg-1 protein) 
1.38 ± 0.04 1.35 ± 0.17 1.09 ± 0.09 1.42 ± 0.23 
Cellular lipids  
(nmol mg-1 protein) 
1.38 ± 0.04 1.34 ± 0.16 1.09 ± 0.09 1.41 ± 0.23 
CO2 
(nmol mg-1 protein) 
0.005 ± 0.0004 0.008 ± 0.0012 0.006 ± 0.0005 0.007 ± 0.0009 
Data are presented as mean ± SEM (n = 5). Different letters indicate statistical differences 
(P ≤ 0.05). 
 
The main metabolic products found in the hepatocytes were the desaturation 
product 18:4 n-3 and the desaturation and elongation products DHA, EPA and 
22:5 n-3. Minor amounts of the “dead end” elongation product 20:3 n-3 were 
also found. 
 
Figure 14 show that approximately 50 % of the radio-activity in cellular lipids 
was recovered as un-metabolised [1-
14
C] 18:3 n-3 substrate. Although not 
statistically significant, more un-metabolised 18:3 n-3 substrate was recovered 
with increased DHA level in hepatocytes. 
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Figure 14: Level of radio-labelled 18:3 n-3 in hepatocytes cultured in one of four fatty 
acid combination (100OA, 75OA/25DHA, 25OA/and 100DHA) and stimulated with 
[1-
14
C] 18:3 n-3 for 24 hours. The quantity of fatty acid is given as percent of total 
radio-labelled fatty acids. Data are presented as mean ± SEM (n = 5).  
 
Approximately 2 % of the total recovered radio-labelled fatty acids were 
found as the Δ6 desaturation product of 18:3 n-3, namely 18:4 n-3 (Figure 15). 
There were no significant differences between the treatment groups in the 
formation of radio-labelled 18:4 n-3, although, there was a tendency to higher 
radio-labelled 18:4 n-3 production in the 100OA group than the groups 
supplemented with DHA in the culture media. 
 
Figure 15: Level of radio-labelled 18:4 n-3 in hepatocytes cultured in one four fatty acid 
combination 100OA, 75OA/25DHA, 25OA/and 100DHA, and stimulated with [1-
14
C] 
18:3 n-3 for 24 hours. The quantity of fatty acid is given in percent of total radio-labelled 
fatty acids. Data are presented as mean ± SEM (n = 5).  
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Increasing DHA content in incubation media led to an increase in this fatty 
acid in hepatocyte lipids which again led to a significant reduction in the 
production of radio-labelled EPA (Figure 16).Radio-labelled EPA production 
from [1-
14
C] 18:3 n-3 decreased from approximately 13 % in the 100OA 
incubated hepatocytes to approximately 11 % in the 75OA/25DHA incubated 
hepatocytes and 10 % in the 25OA/75DHA incubated hepatocytes and 8 % in 
100DHA hepatocytes. 
 
 
Figure 16: Level of radio-labelled EPA in hepatocytes cultured in one of four fatty acid 
combination 100OA, 75OA/25DHA, 25OA/and 100DHA, and stimulated with [1-
14
C] 
18:3 n-3 for 24 hours. The quantity of fatty acid is given in percent of total radio-labelled 
fatty acids. Data are presented as mean ± SEM (n = 5). Different lowercase letters 
indicate statistical differences (P ≤ 0.05). 
 
One-way ANOVA showed that the overall effects of the four fatty acid 
treatments were not significant on n-3 fatty acids production of radio-labelled 
DHA (Figure 17). However, when comparing OA and DHA stimulation, the 
hepatocytes showed a tendency to higher percentage of radio-labelled DHA in 
100OA and 75OA/25DHA incubation than 100DHA and 25OA/75DHA 
incubation. 
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Figure 17: Level of radio-labelled DHA in hepatocytes cultured in one of four fatty acid 
combination 100OA, 75OA/25DHA, 25OA/and 100DHA, and stimulated with [1-
14
C] 
18:3 n-3 for 24 hours. The quantity of fatty acid is given in percent of total radio-labelled 
fatty acids. Data are presented as mean ± SEM (n = 5).  
Although not statistically significant, there is a tendency to decreased 
production of radio-labelled 22:5 n-3 with increasing percentage of DHA in 
the hepatocyte culture media (Figure 18). Percentage of radio-labelled 22:5 
n-3 decreased from approximately 1.75 % in the 100OA incubated 
hepatocytes to approximately 1.5 % in the 75OA/25DHA and 25OA/75DHA 
incubated hepatocytes, to approximately 1.1 % in the 100DHA incubated 
hepatocytes. 
Figure 18: Level of radio-labelled 22:5 n-3 in hepatocytes cultured in one of four fatty 
acid combination 100OA, 75OA/25DHA, 25OA/and 100DHA, and stimulated with 
[1-
14
C] 18:3 n-3 for 24 hours. The quantity of fatty acid is given in percent of total fatty 
acids. Data are presented as mean ± SEM (n = 5).  
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Decreasing OA content in the incubation media was reflected in graded 
increased percentages of radio-labelled 20:3 n-3 (Figure 19). Percentage of 
radio-labelled 20:3 n-3 increased from approximately 9 % in the 100OA 
incubated hepatocytes to approximately 12 % in the 75OA/25DHA and 
25OA/75DHA incubated hepatocytes, to approximately 15 % in the 100DHA 
incubated hepatocytes. 
 
 
Figure 19: Level of radio-labelled 20:3 n-3 in hepatocytes cultured in one of four fatty 
acid combination 100OA, 75OA/25DHA, 25OA/and 100DHA, and stimulated with 
[1-
14
C] 18:3 n-3 for 24 hours. The quantity of fatty acid is given in percent of total fatty 
acids. Data are presented as mean ± SEM (n = 5). Different lowercase letters indicate 
statistical differences (P ≤ 0.05). 
4.2.6 β-oxidation in hepatocytes 
Very small amount of the total uptake of [1-
14
C] 18:3 n-3 was β-oxidised 
(Figure 20). Percentages of β-oxidized [1-14C] 18:3 n-3 relative to uptake in 
100OA incubated cells was significant lower than in cells supplemented with 
DHA. Approximately 0.39 % of [1-
14
C] 18:3 n-3 taken up by the cells was 
β-oxidized in 100OA incubated cells, and approximately 0.58 % was 
β-oxidized in the different DHA supplemented cells. 
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Figure 20: Relative amount of [1-
14
C] 18:3 n-3 β-oxidized compared with total amount of 
[1-
14
C] 18:3 n-3 taken up during the 24 hours incubation time. Data are shown as means 
± SEM (n = 5). Different letters indicate statistical differences (P ≤ 0.05). 
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5. Discussion 
5.1 In vivo trial 
Previous dietary studies with Atlantic salmon have demonstrated that fatty acid 
compositions of fish tissues is determined mainly by the type of dietary lipid 
ingested, and by the ability of the individual fish species to modify that dietary 
input via pathways of desaturation and elongation (Bell et al. 1993; 1995). 
According to Schlechtriem et al. (2007), irrespective of diet, variation exists in 
the content of n-3 HUFA in individual salmon. It means that, when individual 
fish are feed the same dietary fatty acids, there are some variations in the 
content of n-3 HUFA between the individuals. This variation may be due to 
differences in desaturation and elongation capacities in the n-3 HUFA pathway 
between the different individuals. Leaver et al. (2011) has further shown that 
flesh n-3 HUFA composition is a highly heritable trait (h
2 
= 0.77 ± 0.14), which 
indicate that high contents of n-3 HUFA may vary between families. Our goal 
was to identify whether there are differences in the n-3 HUFA level in different 
families. Further to see if there are differences in the capacities to produce n-3 
HUFA. Because of the high costs for measuring fatty acid composition, we have 
used gene expression of Δ6fad as an indirect marker of capacity to produce n-3 
HUFA when screening all the selected salmon families.  
 
∆6fad is regarded as the main enzyme in the n-3 HUFA biosynthesis pathway, 
and ∆6fad activity is far greater than ∆5fad activity in salmon (Hastings et al. 
2004). Three ∆6fad genes (∆6fad_a, ∆6fad_b and ∆6fad_c) are cloned from 
salmon (Monroig et al. 2010). ∆6fad_b showed highest expression level when 
Atlantic salmon hepatocytes are stimulated with fatty acids like OA (previous 
unpublished results from our group). Therefore, it was chosen to analyse the 
expression of Δ6fad_b gene when screening 100 selected salmon families for 
capacities to produce n-3 HUFAs in this in vivo study. 
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The results of our in vivo study showed that the levels of ∆6fad_b gene 
expression in liver were different between the different Atlantic salmon 
families used in our trial. This result may indicate that there are differences 
between different families in their capacities to produce EPA and DHA in 
agreement with the study of Leaver et al. (2011) showing that n-3 HUFA is a 
highly heritable trait in Atlantic salmon. Our data may indicate that 
differences in ∆6fad activity between families may be involved. However, it is 
not known which enzymes in the n-3 HUFA pathway that is responsible for 
the difference. This cannot be stated with certainty based on our data, and 
needs to be further elucidated by actual enzyme measurement and 
determination of fatty acid composition in all the families in addition to the 
gene expression data. Due to high costs, it was only possible to select 12 of 
the 100 families for analyses of fatty acid composition. According to the 
difference found in ∆6fad_b gene expression, 6 families of Atlantic salmon 
were selected as “high expression families” and 6 families were selected as 
“low expression families” and analysed for fatty acid composition.  
 
There were no clear differences in fatty acid compositions between high 
expression families and low expression families when all fish in both groups 
were analysed. There were 5 fish from each family analysed, 30 fish in total 
per selected group. These fish varied markedly in both size and fat content in 
the liver. We found that the EPA and DHA compositions in the high and low 
families were significantly negatively correlated with the fat content of the 
liver. We therefore decided to compare the EPA and DHA content after 
correction for the fat content. After exclusion of the fat content effect, the 
proportions of DHA and EPA tended to be higher in the families with the high 
expression of ∆6fad than in the families with low expression of ∆6fad, 
although not significant. It indicates that increased proportion of DHA and 
EPA may be a result of high expression of ∆6fad. However this result was not 
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significant and it is necessary with analyses of more families in order to 
conclude as to whether there is a connection between gene expression of 
∆6fad and the EPA and DHA content in the fish. Several of the livers in our 
trial had a fat percentage between 15-20 %, which indicate development of 
fatty livers in some of the analysed families, which may have an impact of the 
result since more fatty livers were found in the high expression families than 
in the low expression families. Several factors prior to sampling of the fish 
may have caused the accumulation of fat in the livers. Today it is common 
with 70 % vegetable oil in fish diets and this may markedly influence the liver 
fat content. According to Ruyter et al. (2006) and Kjær et al. (2008), high 
levels of plant oils in the diet for Atlantic salmon lead to higher accumulation 
of fat in the liver than compared to the livers of fish fed a fish oil diet, 
resulting in decreased relative deposition of EPA and DHA in the liver. This 
may be caused mainly by a selective accumulation of 18:2 n-6 and 18:1 n-9. 
This agrees with Olsen and Skjervold (1995), showing that the percentage 
DHA and EPA in the fillet became gradually reduced with increasing fish age 
and fat content. In addition, they also found that body weight is another reason 
which can explain the variation found in n-3 fatty acids in farmed salmon. 
Therefore, we used regression analysis in order to find the correlation between 
DHA and EPA with body weight. We found that the percentages of DHA and 
EPA in the high desaturase families had a negative correlation with individual 
fish weight, increasing with decreasing weight. However, no correlation was 
found between individual weight of fish and percentages of DHA and EPA in 
the low expression families. High expression families compared with low 
expression families, in our study, have higher average body weight. The 
regression analysis result may indicate that individual body weight influence 
the DHA and EPA content in the high expression families.  
 
The peroxisomal ACO is an important enzyme in the last steps in production 
of DHA (Ferdinandusse et al. 2001) and was therefore analysed in our 
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selected extreme groups. There were however, no significant differences in 
ACO activity and ACO gene expression between high expression families and 
low expression families. However, tendency of higher ACO activity and ACO 
gene expression were seen in the high expression families, indicating that high 
∆6fad expression and higher tendency of ACO activity and ACO gene 
expression in high ∆6fad_b expression families may result in higher activity 
of the n-3 HUFA biosynthetic pathway, leading to increased production of 
DHA and EPA. The tendency towards higher DHA and EPA in the high 
∆6fad_b expression families in our experiment is in agreement with this 
explanation. However as also stated above, analyses of more fish in more 
families is necessary in order to make a sound conclusion. 
 
In conclusion this in vivo study indicates that families have different Δ6fad 
gene expressions which possibly influence the capacity to produce n-3 HUFA. 
This may open a way to increase DHA and EPA content in salmon by genetic 
selection.  
 
5.2 In vitro study 
Ruyter and Thomassen (1999) found that Atlantic salmon hepatocytes possess 
the ability to desaturate and elongate C18 n-3 fatty acids to the n-3 HUFAs. In 
our trial, we pre-incubated hepatocytes with OA and DHA and could then use 
hepatocytes as a model system to investigate how differences in endogenous 
level of OA and DHA influence the n-3 fatty acid metabolic pathway. OA and 
DHA were selected as representatives for vegetable oil and fish oil, 
respectively.  
 
In this in vitro study, we found that pre-incubation of salmon hepatocytes with 
different ratios of OA and DHA prior to incubation with radio-labelled 18:3 
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n-3 had effect on the fatty acid composition in hepatocytes. Hepatocytes 
incubated with increased levels of OA had increased percentages of OA and 
its elongation product 20:1 n-9 in cellular lipids. The percentage of DHA in 
hepatocytes was also increased in cells where this fatty acid was 
supplemented in the cultivation media. Our results from fish hepatocytes 
agree with findings from previous in vivo and in vitro studies, which show that 
tissue fatty acid or hepatocytes compositions in salmon is influenced to a huge 
extent by the fatty acids supplemented to the diet or to the cell culture medias 
(Ruyter & Thomassen 1999; Ruyter et al. 2000b; Moya Falcon et al. 2004; 
Kjær et al. 2008). It was a further aim of our study to evaluate how different 
endogenous levels of DHA and OA influence n-3 fatty acid metabolism. 
The composition radio-labelled fatty acids in the hepatocytes after incubation 
with [1-
14
C] 18:3 n-3 was determined by HPLC separation of different fatty 
acids. The main radio-labelled products were the desaturation product 18:4 
n-3 and the desaturation and elongation products EPA, DHA and 22:5 n-3.  
 
Recovery of unmetabolised [1-
14
C] 18:3 n-3 substrate in the cells tended to 
decreased with increased percentage of OA in the cells, indicating that more 
of the radio-labelled 18:3 n-3 substrate has been converted to other metabolic 
products in the groups incubated with OA than in those incubated with high 
levels of DHA. There were no significant differences in the level of [1-
14
C] 
18:4 n-3 produced in the hepatocytes of the various treatment groups, 
although the 100OA group tended to have the highest level of radio-labelled 
18:4 n-3. This indicate that the rate of the first step in the conversion of 18:3 
n-3 to DHA by ∆6 desaturation to form 18:4 n-3 was increased by increased 
proportion of OA and decreased proportion of DHA in the culture media. This 
result is consistent with Ruyter and Thomassen (1999). In addition, this result 
fit the expression of ∆6fad_b in our in vitro study that was stimulated by 
increased level of OA in the incubation medium.  
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There was further a significant higher production of radio-labelled 20:5 n-3 
from [1-
14
C] 18:3 n-3 with increasing OA in the cells. An explanation for this 
significant higher radio-labelled EPA in the OA groups was probably due to an 
increased ∆6fad_b activity. Elongation reactions are not usually considered as 
major control steps in fatty acid metabolism (Thomassen et al. 2012). Neither 
is ∆5fad regarded as the main rate limiting enzyme in the n-3 HUFA 
biosynthesis pathway in salmon (Hastings et al. 2004). Therefore, increased 
∆6fad activity, as a main regulation enzyme of HUFA biosynthesis, may be 
the most important factor explaining the elevated EPA production in our trial, 
which agrees with the findings of Alimuddin et al. (2005).  
 
 
Although there were no significant differences in percentage of radio-labelled 
DHA produced between cells incubated with OA and DHA, there was a 
tendency to higher production of radio-labelled DHA in the high OA groups 
than in the high DHA groups. This result is in agreement with a previous study 
where it was shown that vegetable oil can stimulate Δ6fad gene expression 
(Thomassen et al. 2012; Skrzypski et al. 2009; Vagner & Santigosa 2011). 
 
The gene expression analysis of ACO and measurement of ACO enzyme 
activity show tendency to increase with increased DHA stimulation of 
hepatocytes. These results agree with previous findings in an in vivo study, 
showing both increased ACO enzyme activity and ACO gene expression when 
fed high DHA levels (Kjær et al. 2008). Also other earlier studies with 
Atlantic salmon are showing that hepatic β-oxidation activity is affected by 
the type of input fatty acid (Torstensen & Stubhaug 2004). According to 
Torstensen and Stubhaug, the total β-oxidation activity of [1-14C] 18:3 n-3 was 
higher in hepatocytes stimulated with DHA than stimulated with OA. 
Therefore, OA probably reduce fatty acid β-oxidation leading to decreased 
energy production. 
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In summary, the results from this in vitro study indicates that pre-incubation of 
salmon hepatocytes with increasing ratios of OA may increase the EPA and 
DHA synthesis. The expression of ∆6fad_b in our in vitro study is stimulated 
by increased level of OA in the incubation medium.  
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Concluding remarks  
The in vivo study indicates that families have different Δ6fad_b gene 
expression, which possibly influences the capacity to produce n-3 HUFA. 
When comparing high and low expression families, there were a tendency of 
higher DHA and EPA content in liver tissue in high gene expression families. 
This may indicate that it is possible to produce Atlantic salmon families with 
an enhanced capacity to produce DHA and EPA content through selective 
breeding of families with high Δ6fad gene expression. However, analyses of 
more families are necessary to certificate this connection.  
 
The in vitro study indicates that increasing level of OA may increase the EPA 
and DHA synthesis in salmon hepatocytes. The expression of ∆6fad_b in our 
in vitro study is stimulated by increased level of OA in the incubation 
medium.  
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